Top 8 manufacturers in Generic Active Pharmaceutical Ingredients Market
By Prof Researh
Updated 02:00:18 November 06, 2019
.
Updated 02:00:18 November 06, 2019
Prof Resear published a new Market report on Generic Active Pharmaceutical Ingredients Market. It present the largest 8 manufacruers in Generic Active Pharmaceutical Ingredients Market. The report is a professional and in-depth study on the current state of the global Generic Active Pharmaceutical Ingredients market with a focus on the Chinese market. The report provides key statistics on market of Generic Active Pharmaceutical Ingredients. It is a valuable source of guidance and direction for companies and individuals interested in Generic Active Pharmaceutical Ingredients industry.
.
Pfizer
Ref A: 85041DB3287C43B4A5253EDFC8F2EA1B Ref B: SJCEDGE0222 Ref C: 2019-11-06T06:00:02Z
Inc. (U.S.)
An Inc . Verified Profile is the perfect tool for helping entrepreneurs and small companies showcase their companies in attention-grabbing context. Whether you want to drum up new customers, seek ... Visit Inc.com for the latest issue of Inc . Magazine and get advice, tools, and services that help your small business grow. About U S Liquids Inc . U S Liquids Inc . provided liquid waste management services, including collection, processing, recovery and disposal services. In July 2003, the Company completed the sale of ...
Novartis International AG (Switzerland)
Novartis International AG /Switzerland Novartis International AG was founded in 1886. The companys line of business includes providing various business services. Our purpose is to reimagine medicine to improve and extend peoples lives. We use innovative science and technology to address some of societys most challenging healthcare issues. We discover and develop breakthrough treatments and find new ways to deliver them to … About Novartis AG (ADR ) Novartis AG is a holding company, which provides healthcare solutions. The Company is engaged in the research, development, manufacturing and marketing of a range of...
Sanofi (France)
Ref A: EC48708372EE419CBD5DCA8F98866E05 Ref B: SJCEDGE0418 Ref C: 2019-11-06T06:00:11Z
Boehringer Ingelheim (Germany)
Ref A: E0DBA10BD93943A69C4E86676E03F0EC Ref B: SJCEDGE0216 Ref C: 2019-11-06T06:00:13Z
Bristol-Myers Squibb (U.S.)
Ref A: ACCCCDDD6EF34BB5BC59CBDE90D84518 Ref B: SJCEDGE0416 Ref C: 2019-11-06T06:00:14Z
Teva Pharmaceutical Industries Ltd. (Israel)
Ref A: 29C525535B1842A69A64376F4CDC13CE Ref B: SJCEDGE0409 Ref C: 2019-11-06T06:00:16Z
Eli Lilly and
Ref A: B10519451D2A4709886C04AD29CA4E93 Ref B: SJCEDGE0415 Ref C: 2019-11-06T06:00:18Z